| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 31 |
| 1 | ASPIRIN | 26 |
| 2 | ASPIRIN 325 MG | 26 |
| 3 | ASPIRIN 81 MG | 26 |
| 4 | MYCOPHENOLATE MOFETIL | 26 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 26 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 7 | TACROLIMUS OINTMENT 0.1% | 25 |
| 8 | CYCLOSPORINE | 14 |
| 9 | FUROSEMIDE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ACELLULAR TISSUE ENGINEERED VESSEL | 4 | 0.3636 |
| 1 | HYDROCODONE BITARTRATE AND IBUPROFEN | 1 | 0.0021 |
| 2 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 3 | LANTHANUM CARBONATE | 6 | 0.0012 |
| 4 | TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0011 |
| 5 | LIDOCAINE AND PRILOCAINE | 1 | 0.0007 |
| 6 | EPOETIN ALFA | 6 | 0.0005 |
| 7 | ESTAZOLAM | 1 | 0.0005 |
| 8 | BASILIXIMAB | 6 | 0.0005 |
| 9 | IMIPENEM AND CILASTATIN SODIUM | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin D2 Analog [EPC] | 3 | 0.0004 |
| 1 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 2 | PCSK9 Inhibitor [EPC] | 6 | 0.0002 |
| 3 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 4 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 5 | Vitamin D Analog [EPC] | 4 | 0.0002 |
| 6 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 7 | Lipopeptide Antibacterial [EPC] | 2 | 0.0002 |
| 8 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 9 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |